Bionsight
Latest round
- —
Last raised
- Nov 2026
Total raised
- $15M
Investors
- 3
About Bionsight
Based in Seoul, South Korea, and founded in 2019, Bionsight Inc. operates as a drug discovery company that uses artificial intelligence for target identification and off-target profiling within the drug development process. In August 2023, Bionsight, Inc. The drug discovery company uses an artificial intelligence-based "Javelin" chemo proteomics platform that conducts pharmaceutical development processes, which include target verification, de novo drug design, and results analysis.
Who invested in Bionsight
3 investors across 2 rounds
See all investors in Bionsight
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bionsight
Who invested in Bionsight?
Bionsight has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bionsight raised?
Bionsight has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
What does Bionsight do?
Based in Seoul, South Korea, and founded in 2019, Bionsight Inc.
Where is Bionsight headquartered?
Bionsight is headquartered in Chuncheon, South Korea.
Which VCs invest in companies like Bionsight?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Bionsight's stage. Their profiles are linked below.
VCs backing biotechnology startups
Raising like Bionsight? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.